Breyanzi (lisocabtagene maraleucel) - BMS
oxaliplatin - Generic mfg.
gemcitabine - Generic mfg.
Gazyva (obinutuzumab) - Roche, Biogen
cyclophosphamide - Generic mfg.
Columvi (glofitamab-gxbm) - Roche
fludarabine IV - Generic mfg.
GLORY: Glofit-GemOx With Liso-Cel For Lymphoma (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=56 | Recruiting | Sponsor: Massachusetts General Hospital | Not yet recruiting ➔ Recruiting | Trial completion date: Oct 2030 ➔ Mar 2032 
Enrollment open • Trial completion date • B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Indolent Lymphoma • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Primary Central Nervous System Lymphoma • BCL2 • BCL6
http://clinicaltrials.gov/ct2/show/NCT07711483
 
Oct 23, 2026
 
Prev Next